Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1902141914
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 Route 112 Bldg 4
Port Jefferson Station, NY, 11776
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
406,613 services
Medicare patients, 2024
3,110
Average age 74
Drug cost, 2024
$8.4M
1,731 prescriptions
Company payments, 2025
$158
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amishi Desai was code J1439 (injection, ferric carboxymaltose, 1 mg), 168,751 times for 160 patients. In total Amishi Desai billed 406,613 services in 303 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 168,751 | 160 | $0.87 | $146K |
| J1756 Injection, iron sucrose, 1 mg | Office | 32,802 | 82 | $0.17 | $5,598 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,200 | 29 | $44.35 | $852K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 16,101 | 21 | $2.27 | $37K |
| J0897 Injection, denosumab, 1 mg | Office | 10,980 | 80 | $20.40 | $224K |
| J9267 Injection, paclitaxel, 1 mg | Office | 9,107 | 19 | $0.08 | $741 |
| 85025 Blood Count | Office | 4,807 | 1,978 | $7.56 | $36K |
| 36415 Venipuncture Blood Collection | Office | 4,746 | 1,911 | $8.64 | $41K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,705 | 195 | $0.09 | $408 |
| 88185 Surgical Pathology Examination | Office | 4,671 | 195 | $21.85 | $102K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,790 | 15 | $34.52 | $131K |
| 80053 Clinical Chemistry | Office | 3,479 | 1,693 | $10.27 | $36K |
| 84100 Clinical Chemistry | Office | 2,090 | 1,204 | $4.61 | $9,637 |
| 82728 Clinical Chemistry | Office | 1,958 | 1,130 | $13.24 | $26K |
| 83540 Clinical Chemistry | Office | 1,925 | 1,110 | $6.28 | $12K |
By year: 2022 $1.4M for 113,095 services; 2023 $4.1M for 324,171 services; 2024 $4.9M for 406,613 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 4,807 | 1,978 | $7.56 | $36K |
| 36415 Venipuncture Blood Collection | 4,746 | 1,911 | $8.64 | $41K |
| 88185 Surgical Pathology Examination | 4,671 | 195 | $21.85 | $102K |
| 80053 Clinical Chemistry | 3,479 | 1,693 | $10.27 | $36K |
| 84100 Clinical Chemistry | 2,090 | 1,204 | $4.61 | $9,637 |
| 82728 Clinical Chemistry | 1,958 | 1,130 | $13.24 | $26K |
| 83540 Clinical Chemistry | 1,925 | 1,110 | $6.28 | $12K |
| 83550 Clinical Chemistry | 1,911 | 1,100 | $8.50 | $16K |
| 83735 Clinical Chemistry | 1,911 | 1,075 | $6.52 | $12K |
| 83615 Clinical Chemistry | 1,859 | 1,063 | $5.88 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Amishi Desai prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 199 prescriptions and refills. In total Amishi Desai wrote 1,731 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 199 | 199 | 44 | $467K |
| Xgeva Denosumab | 100 | 100 | 15 | $300K |
| Revlimid Lenalidomide | 65 | 65 | Under 11 | $1.0M |
| Akynzeo Fosnetupitant/Palonosetron | 58 | 58 | 21 | $59K |
| Eliquis Apixaban | 57 | 98 | 20 | $57K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 55 | 55 | Under 11 | $380K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 49 | 49 | Under 11 | $610K |
| Zarxio Filgrastim-Sndz | 37 | 37 | 15 | $29K |
| Dexamethasone Generic | 32 | 35 | 20 | $729 |
| Ondansetron Odt Ondansetron | 32 | 32 | 26 | $445 |
| Xarelto Rivaroxaban | 30 | 76 | 12 | $41K |
| Keytruda Pembrolizumab | 27 | 27 | Under 11 | $304K |
| Mvasi Bevacizumab-Awwb | 26 | 26 | Under 11 | $154K |
| Prednisone Generic | 26 | 31 | 11 | $170 |
| Bortezomib Generic | 26 | 26 | Under 11 | $26K |
Brand drugs: 1,102 claims; generic drugs: 629 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amishi Desai $158 ($158 in general payments such as food, travel and fees) from 3 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $108.
| Company | Payments | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $108 |
| Dendreon Pharmaceuticals LLC | 1 | $27.41 |
| Menarini Silicon Biosystems, Inc. | 1 | $23.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.